Crateva adansonii

Crateva adansonii

Crateva adansonii

Common Names: Sacred garlic pear, Varun, Three-leaf caper, Barna
Local Names: Amakarode ( (Igbo,Nigeria), Eegun-orun (Yoruba, Nigeria), Bududu , Gude , Ingidido, Ingidudu,  Kalu, Gudai (Hausa, Nigeria)
Species ID: NMP-025 |
wfo-0000625674 | NCBI:txid190806

Scientific Classification

Kingdom: Plantae

Clade: Tracheophytes

Clade: Angiosperms

Clade: Eudicots

Clade: Rosids

Order: Brassicales

Family: Capparaceae

Genus: Crateva

Species: C. adansonii

Synonyms: Crateva guineensis Schumach. & Thonn., Crateva laeta DC., Crateva religiosa var. brevistipitata De Wild.

Morphological Description

Crateva adansonii is a deciduous tree, typically growing 5–25 meters tall, with a spreading canopy. Its key characteristics include:

·       Bark: Rough, greyish-brown, often fissured, used medicinally for its bioactive compounds.

·       Leaves: Trifoliate, with elliptical to ovate leaflets (5–12 cm × 2–5 cm), glossy, dark green, with entire margins; petioles 3–8 cm long (Burkill, 1985).

·       Flowers: Fragrant, white to pale yellow, 3–5 cm in diameter, arranged in terminal corymbs; petals are clawed, and long, spidery stamens give a crown-like appearance.

·       Fruit: Globose to pear-shaped capsules (3–5 cm), green turning brown, containing numerous seeds embedded in a pulpy matrix; edible but rarely consumed.

Distribution and Habitat

Crateva adansonii is widely distributed in tropical regions, particularly in Africa, with some presence in Asia:

·       Geographic Range: Native to West and Central Africa (Senegal, Nigeria, Cameroon, Gabon, DR Congo); extends to East Africa (Uganda, Tanzania) and parts of Asia (India, Sri Lanka); cultivated in Nigeria for medicinal and ornamental purposes.

·       Habitat: Thrives in lowland forests, riverbanks, savanna woodlands, and coastal areas; prefers moist, well-drained soils (pH 5.5–7.0) with annual rainfall of 800–2,000 mm; tolerates elevations up to 1,200 m.

·       Ecological Role: Stabilizes riverbanks and supports pollinators like bees and butterflies; its fruits are dispersed by birds and mammals, contributing to forest regeneration.

Ethnopharmacology

Crateva adansonii, commonly known as the sacred garlic pear or three-leaf caper, is a medicinal plant traditionally used in various parts of Africa and Asia. Its bark, leaves, roots, and fruits are rich in bioactive compounds and are widely employed for their anti-inflammatory, analgesic, antioxidant, antimicrobial, antidiabetic, hepatoprotective, and diuretic properties. In traditional medicine, the bark is often used to treat rheumatism, urinary tract infections, and fevers, while the leaves are used in managing wounds, abscesses, and digestive disorders. The plant is also known to support kidney and liver function, and its extracts have shown potential in alleviating arthritis and jaundice. Phytochemical studies have identified the presence of flavonoids, saponins, alkaloids, tannins, and triterpenoids, which contribute to its pharmacological actions. Despite its broad traditional use, more clinical research is necessary to fully substantiate its efficacy and safety for modern therapeutic applications.

·       Anti-inflammatory: In Nigeria, bark extracts treat rheumatism. Methanol leaf extracts (400 mg/kg) reduced carrageenan-induced paw edema by 61% in rats, linked to lupeol and flavonoids (Rathinavel et al., 2021).

·       Analgesic: In Cameroon, leaf sap relieves pain. Methanolic stem-bark extracts (400 mg/kg) increased pain reaction time by 94.76% in rats, surpassing pentazocine (3 mg/kg) in hot plate assays (Akanji et al., 2013).

·       Diuretic and Anti-urolithiatic: In Benin, bark decoctions treat urinary issues. Petroleum ether bark extracts (200 mg/kg) reduced calcium oxalate crystals by 50% in rat kidneys, promoting urine output by 35% (Gupta et al., 2006).

·       Antimicrobial: In Togo, leaves treat abscesses. Ethanol leaf extracts exhibited MIC values of 125–250 μg/mL against Staphylococcus aureus and Pseudomonas aeruginosa, validating wound-healing applications (Ahama-Esseh et al., 2017).

·       Anticancer: In Cameroon, bark is used for tumors. Dichloromethane/methanol bark extracts (75 mg/kg) reduced mammary tumor burden by 88.64% in DMBA-induced rats, with daucosterol as a key active compound (Zingue et al., 2016). Daucosterol, a compound isolated from C. adansonii, demonstrated significant in vivo anticancer effects by reducing 7,12-dimethylbenz(a)anthracene (DMBA)-induced breast tumor volume by 48.5% and tumor weight by 40% in Wistar rats treated with 10 mg/kg for 20 weeks. The compound also modulated estrogen receptor expression, indicating its potential in breast cancer therapy (Nguedia et al., 2020).

·       Analgesic and Antioxidant Activity: The hydromethanolic extract of Crateva adansonii stem bark exhibited significant analgesic activity, reducing acetic acid-induced writhing in mice by 54.3% at 400 mg/kg and increasing pain latency in the hot plate test by 68.2% compared to controls. Additionally, it demonstrated notable antioxidant properties, scavenging 72.4% of DPPH radicals at 100 µg/mL, supporting its traditional use in pain management and oxidative stress-related conditions (Udeh & Onoja, 2015).

·       Antiplasmodial Activity: The aqueous leaf extract of C. adansonii showed a 61.35% inhibition of Plasmodium berghei parasitemia in infected mice at a dose of 400 mg/kg, with a dose-dependent reduction in parasite density observed over 4 days. The extract's LD50 was determined to be 3,500 mg/kg in acute toxicity studies, indicating a relatively high safety margin for oral administration (Tsado et al., 2020).

·       Antihyperglycemic and Antioxidant Effects: The hydroethanolic extract of C. adansonii leaves significantly reduced blood glucose levels by 45.6% in glucose-loaded hyperglycemic mice at 400 mg/kg within 2 hours. It also exhibited antioxidant activity, inhibiting lipid peroxidation by 60.2% and increasing catalase activity by 35% in liver homogenates, suggesting its potential in managing diabetes mellitus and associated oxidative stress (Kokou et al., 2020).

⚠  Toxicity Profile: Crateva adansonii is generally safe at therapeutic doses, but high doses may cause toxicity. Aqueous leaf extracts (up to 5,000 mg/kg) showed no acute toxicity (LD₅₀ > 5,000 mg/kg) in rats, but subchronic use increased serum ALP and γ-GT levels, indicating potential liver and kidney stress (Akanji, 2013).

Additional Uses

·       Culinary: Young leaves are occasionally cooked as a vegetable in Nigeria, added to soups for their mucilaginous texture.

·       Ornamental: Planted for its attractive flowers and shade in gardens and along riverbanks in Cameroon and India.

·       Environmental: Used in agroforestry to stabilize riverbanks and enhance soil fertility; its fruits support local wildlife.

References

  • Aham-Esseh, K., Bodet, C., Quashie-Mensah-Attoh, A., Garcia, M., Théry-Koné, I., Dorat, J., ... & Boudesocque-Delaye, L. (2017). Anti-inflammatory activity of Crateva adansonii DC on keratinocytes infected by Staphylococcus aureus: From traditional practice to scientific approach using HPTLC-densitometry. Journal of Ethnopharmacology, 204, 26–35.
  • Akanji, M. A. (2013). Safety evaluation of aqueous extract of Crateva adansonii leaves on selected tissues of rats. Fountain Journal of Natural and Applied Sciences, 2(1), 17–28.
  • Gupta, P., Patel, N., Bhatt, L., Zambare, G. N., Bodhankar, S. L., Jain, B. B., & Nandakumar, K. (2006). Anti-urolithiac effect of petroleum ether extract stem bark of Crateva adansonii in rats. Pharmaceutical Biology, 44(3), 160–165.
  • Kokou, A., Povi, L. E., Kossi, M., Batomayena, B., Kwashie, E. G., Kodjo, A., & Mensavi, G. (2020). Antihyperglycaemic and antioxidant activities of Crataeva adansonii DC. ssp. adansonii leaves extract on ICR mice. Journal of Drug Delivery & Therapeutics, 10(5-s), 92–99.
  • Nguedia, M. Y., Tueche, A. B., Yaya, A. J. G., Yadji, V., Ndinteh, D. T., Njamen, D., & Zingue, S. (2020). Daucosterol from Crateva adansonii DC (Capparaceae) reduces 7,12-dimethylbenz(a)anthracene-induced mammary tumors in Wistar rats. Environmental Toxicology, 35(10), 1125–1136.
  • Rathinavel, T., Ammashi, S., & Shanmugam, G. (2021). Analgesic and anti-inflammatory potential of lupeol isolated from Indian traditional medicinal plant Crateva adansonii screened through in vivo and in silico approaches. Journal of Genetic Engineering and Biotechnology, 19(1), 62.
  • Tsado, A., Jigam, A., Akanya, H., Ossamulu, I., & Ariyeloye, S. (2020). Acute toxicity studies and anti-plasmodial potentials of Newbouldia laevis and Crateva adansonii in Plasmodium berghei-infected mice. Iranian Journal of Toxicology, 14(2), 93–100.
  • Udeh, N. E., & Onoja, S. O. (2015). Analgesic and free radical scavenging activities of hydromethanolic extract of Crateva adansonii stem bark. Journal of Intercultural Ethnopharmacology, 4(3), 224–227.
  • Zingue, S., Cisilotto, J., Tueche, A. B., Bishayee, A., Mefegue, F. A., Sandjo, L. P., ... & Njamen, D. (2016). Crateva adansonii DC, an African ethnomedicinal plant, exerts cytotoxicity in vitro and prevents experimental mammary tumorigenesis in vivo. Journal of Ethnopharmacology, 190, 183–199.

External Links

More Pictures

 

Compounds of Crateva adansonii
References


Sanyaolu, N. O., Agboyinu, E. B., Yussuf, S. T., Sonde, O. I., Avoseh, O. N., & Ibikunle, A. A. (2019). Chemical composition and insecticidal activity of the essential oils of Crateva adansonii DC. Leaf on Sitophilus zeamais and Callosobrunchus maculatus. Ife Journal of Science, 21(3), 129-137.